(MXCT)

Financial Scores

What is the investor’s view on MaxCyte Inc (MXCT)?

Cameron Mitchell

While MaxCyte Inc has underperformed by -3.28%, investors are advised to look at stock chart patterns for technical insight. Within ...

Stocks Trading

MaxCyte Inc (MXCT) stock: A year of ups and downs

Cameron Mitchell

While MaxCyte Inc has overperformed by 6.21%, investors are advised to look at stock chart patterns for technical insight. Within ...

Financial Scores

What is the investor’s view on MaxCyte Inc (MXCT)?

Kenneth Phillips

While MaxCyte Inc has underperformed by -7.83%, investors are advised to look at stock chart patterns for technical insight. Within ...

Analyst Snapshot

How does MXCT’s price to cash per share ratio compare in the market?

Patricia Turner

Currently, MaxCyte Inc’s (MXCT) stock is trading at $1.6, marking a fall of -1.54% from last night’s close. At this ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.